2018
- Endocrine Society Report: Action on Endocrine Disrupting Chemicals - Public Health Opportunities for Europe | November 19, 2018
- Action on Endocrine-Disrupting Chemicals–Public Health Opportunities for Europe—Slides from the Endocrine Society's November European Parliament Briefing
- Endocrine Society comments on EFSA call for data relevant to the hazard assessment of Bisphenol A (BPA) | October 15, 2018
- Comments on Guiding Principles to Apply to Systematic Review in TSCA | August 16, 2018
- Endocrine Society Comments on European Commission Proposal for Revised EU EDC Strategy | July 18, 2018
- Endocrine Society Concerned Proposed EPA Transparency Rule Will Restrict Ability to Develop and Implement Effective Restrictions on Hazardous Chemicals | May 21, 2018
- Endocrine Society Expresses Concerns about Conclusions Drawn from CLARITY-BPA Study | April 9, 2018
- Endocrine Society Comments on Draft of Modernization of Cosmetics Regulation Act, Recommends Greater Protections against EDCs | March 14, 2018
- EDCs in the EU: Endocrine Society Urges European Agencies to Revise Their EDC Identification Process | January 31, 2018
- Endocrine Society to EPA: Hazard Is More Important than Exposure When Evaluating New Chemicals | January 22, 2018
- Endocrine Society Advises EPA on How to Improve Its Review of New Chemicals | January 19, 2018
2017
- Endocrine Society Endorsement of the Personal Care Products Safety Act | September 27, 2017
- Endocrine Society Comments on EFSA Revised BPA Review Protocol | August 24, 2017
- Joint Letter from Endocrine Society, ESE, and ESPE Regarding EDC Criteria Implementation | July 11, 2017
- Joint Letter to EU Member State Ministers Regarding the EDC Criteria | June 15, 2017
- Endocrine Society Comments on EFSA Draft Guidance on Establishing Biological Relevance | April 28, 2017
- Endocrine Society Letter to European Commission President Juncker and First Vice President Timmermans Regarding EDC Criteria Proposal | April 2, 2017
- Endocrine Society Comments on New Chemicals Review Program | January 17, 2017
2016
- Endocrine Society Comments to EPA on Draft Risk Assessment for Atrazine | October 3, 2016
- Sign-On Letter to Senate HELP Committee Leadership in Support of the Personal Care Products Safety Act | August 30, 2016
- Endocrine Society Comments to EPA on Risk Evaluation and Chemical Prioritization | August 22, 2016
- Endocrine Society Response to European Commission Proposed Criteria on EDCs | July 27, 2016
- Endocrine Society Response to FDA Petition on Phthalates | July 14, 2016
